NCT07696728 Pulsed Electromagnetic Field Therapy for Diabetic Foot Ulcer Sensation
| NCT ID | NCT07696728 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Faisalabad |
| Condition | Diabetes Mellitus (DM) |
| Study Type | INTERVENTIONAL |
| Enrollment | 42 participants |
| Start Date | 2026-07-07 |
| Primary Completion | 2026-08-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 42 participants in total. It began in 2026-07-07 with a primary completion date of 2026-08-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Diabetes Mellitus (DM) is a chronic metabolic disorder characterized by hyperglycaemia for extended periods of time, which causes damage to peripheral nerves, resulting in sensory, motor and autonomic dysfunction. The study will aim to assess the effect of the Low pulse electromagnetic field therapy in VPT and protective sensation in the diabetic foot ulcer. The total number of participants will be 42 (calculated by epi tool) and the participants are to be divided among two groups. Non Probability Consecutive sampling technique will be used for this study. The data collection tools will be Wagner Classification System for Diabetic Foot Ulcers, Numerical Pain Rating Scale, Goniometry, 10 g monofilament, Tuning Fork 128 Hz will be used. After meeting the inclusion and exclusion criteria and taking the written and verbal informed consent participants in one group will receive (low frequency pulsed electromagnatic field therapy and ankle Range of Motion) and other group will be receive (Sham PEMF and ankle Range of motion). Both interventions will be given three times weekly (or every other day) for 6 weeks. Vibrations perception, protective sensation, pain, ankle ROM and will be the outcome measures of the study. The data will be collected at baseline and 6 weeks. The data will be analyzed by using SPSS 23 and interpreted by using MS Word.
Eligibility Criteria
Inclusion Criteria: * Participants must have a clinical diagnosis of Type 2 diabetes (HbA1c ≥ 6.5) (Bolen et al., 2016). * Patients with Wagner grade 1 diabetic foot ulcers was selected. * Michigan Neuropathic Screening Instrument history score ≤7 (Viswanathan et al., 2025). * Participants showing reduced vibration perception threshold on 128Hz Tunning fork was included to confirm the presence of sensory neuropathy Associated with diabetic ulcers (Viswanathan et al., 2025). * Sensation on 10g monofilament less then 8 point out of 10 indicate reduces Sensation. * Participants having diabetes for more than 10 years (Grewal et al., 2015). * Pariticipants aged between 40 to 60 years. * Both gender were included. * Participants who was willing to give consent. Exclusion Criteria: * Participants who have significant cognitive impairment (e.g Dementia, Alzheimer) that would prevent them from understanding and adhering to Study instructions. * Participants with active infections requiring systemic antibiotic therapy (Kwan et al., 2015). * Patients with comorbidities such as malignancy, severe renal disease, or Other systemic condition. * Participants who was not taking any medicine
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07696728 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Diabetes Mellitus (DM). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07696728 currently recruiting?
Yes, NCT07696728 is actively recruiting participants. Contact the research team at drrubinazulfqar355@gmail.com for enrollment information.
Where is the NCT07696728 trial being conducted?
This trial is being conducted at Faisalabad, Pakistan.
Who is sponsoring the NCT07696728 clinical trial?
NCT07696728 is sponsored by University of Faisalabad. The trial plans to enroll 42 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.